| Pharmaceutical active ingredients: |
| LansoprazoleNaproxen |
| Available forms, composition and doses of Prevacid NapraPAC: |
| Capsules, Delayed Release, Oral; Lansoprazole 15 mg / Tablet; Oral; Naproxen 250 mgCapsules, Delayed Release, Oral; Lansoprazole 15 mg / Tablet; Oral; Naproxen 375 mgCapsules, Delayed Release, Oral; Lansoprazole 15 mg / Tablet; Oral; Naproxen 500 mg |
| Prevacid NapraPAC medical category: |
| Human:Proton-Pump inhibitors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A02BC03 - LansoprazoleM01AE02 - NaproxenM02AA12 - Naproxen |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Takeda PharmaceuticalTanta Pharmaceuticals |
| Related documents and information about Prevacid NapraPAC: |
| Prevacid prescribing information (PDF)Prevacid I.V. prescribing information (PDF)Prevacid NapraPAC prescribing information (PDF) |